The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring

被引:36
作者
Beck, Roy [1 ]
Steffes, Michael [2 ]
Xing, Dongyuan [1 ]
Ruedy, Katrina [1 ]
Mauras, Nelly [3 ]
Wilson, Darrell M. [4 ]
Kollman, Craig [1 ]
机构
[1] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA
[2] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[3] Nemours Childrens Clin, Jacksonville, FL 32256 USA
[4] Stanford Univ, Div Pediat Endocrinol & Diabet, Stanford, CA 94305 USA
关键词
1; 5-AG; hemoglobin A1c; type 1 diabetes mellitus; SERUM 1,5-ANHYDROGLUCITOL; CLINICAL MARKER; PLASMA-GLUCOSE; EXCURSIONS; 1,5-ANHYDRO-D-GLUCITOL; HBA(1C); NIDDM;
D O I
10.1111/j.1399-5448.2011.00764.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To describe the interrelationships of glycemic control measures: hemoglobin A1c (HbA1c), glycated albumin, fructosamine, 1,5-anhydroglucitrol (1,5-AG), and continuous glucose monitoring (CGM) in children and adolescents with type 1 diabetes. Methods: In total, 26 subjects of age 4-17 had HbA1c measurement followed within 14 d by three laboratory measures of glycemia and the collection of CGM glucose data (N = 21). Results: Glycated albumin and fructosamine levels had a higher correlation with each other than with HbA1c. The correlation of 1,5-AG with HbA1c was lower (absolute r value = 0.25). All four measures had a similar degree of correlation with CGM-measured mean glucose (absolute r value = 0.50-0.56) and with hyperglycemic area under the curve (AUC) at 180 mg/ dL (0.50-0.60). Conclusion: Each of the four measures (i. e., HbA1c, glycated albumin, fructosamine, and 1,5-AG) had a similar correlation with mean glucose and hyperglycemic AUC-180. 1,5-AG did not correlate with hyperglycemic AUC-180 better than did HbA1c.
引用
收藏
页码:690 / 695
页数:6
相关论文
共 16 条
[1]  
Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839
[2]   1,5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes [J].
Dungan, Kathleen M. ;
Buse, John B. ;
Largay, Joseph ;
Kelly, Mary M. ;
Button, Eric A. ;
Kato, Shuhei ;
Wittlin, Steven .
DIABETES CARE, 2006, 29 (06) :1214-1219
[3]  
*GLYCOMARK, 2008, GLYCOMARK ASS OV
[4]   1,5-ANHYDRO-D-GLUCITOL EVALUATES DAILY GLYCEMIC EXCURSIONS IN WELL-CONTROLLED NIDDM [J].
KISHIMOTO, M ;
YAMASAKI, Y ;
KUBOTA, M ;
ARAI, K ;
MORISHIMA, T ;
KAWAMORI, R ;
KAMADA, T .
DIABETES CARE, 1995, 18 (08) :1156-1159
[5]   CORRELATION OF GLUCOSE REGULATION AND HEMOGLOBIN-A-IC IN DIABETES-MELLITUS [J].
KOENIG, RJ ;
PETERSON, CM ;
JONES, RL ;
SAUDEK, C ;
LEHRMAN, M ;
CERAMI, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (08) :417-425
[6]   Symmetrization of the blood glucose measurement scale and its applications [J].
Kovatchev, BP ;
Cox, DJ ;
GonderFrederick, LA ;
Clarke, W .
DIABETES CARE, 1997, 20 (11) :1655-1658
[7]   Circulating 1,5-anhydroglucitol levels in adults patients with diabetes reflect longitudinal changes of glycemia [J].
McGill, JRB ;
Cole, TG ;
Nowatzke, W ;
Houghton, S ;
Ammirati, EB ;
Gautille, T ;
Sarno, MJ .
DIABETES CARE, 2004, 27 (08) :1859-1865
[8]   Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions?: Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine [J].
Moses, A. C. ;
Raskin, P. ;
Khutoryansky, N. .
DIABETIC MEDICINE, 2008, 25 (02) :200-205
[9]   Defining the relationship between plasma glucose and HbA1c -: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial [J].
Rohlfing, CL ;
England, JD ;
Wiedmeyer, HM ;
Tennill, A ;
Little, RR ;
Goldstein, DE .
DIABETES CARE, 2002, 25 (02) :275-278
[10]   MEAN AMPLITUDE OF GLYCEMIC EXCURSIONS, A MEASURE OF DIABETIC INSTABILITY [J].
SERVICE, FJ .
DIABETES, 1970, 19 (09) :644-&